期刊文献+

溶血卵磷脂对L-20细胞SRBI表达的影响及辛伐他汀的干预作用

The effect of lysophosphatidyl choline on the expression of scavenger receptor class B type Ⅰ in L-20 cells and the impact of simvastatin
原文传递
导出
摘要 目的观察溶血卵磷脂(LPC)及辛伐他汀干预对体外培养人肝细胞(L-20)SRB I表达的影响。方法培养的肝细胞随机分为正常组、LPC损伤组及辛伐他汀组。分别用逆转录聚合酶链式反应(RT-PCR)、免疫细胞化学和蛋白质免疫印迹(W esternb lot)方法观察肝细胞SRB I基因和蛋白表达的变化。结果LPC损伤组肝细胞SRB I基因和蛋白表达水平较正常组增强(P<0.05);辛伐他汀组肝细胞SRB I基因和蛋白表达水平均高于LPC损伤组(均P<0.05)。结论LPC损伤肝细胞后,SRB I基因和蛋白表达水平轻度上调;辛伐他汀干预可明显上调体外培养的肝细胞SRB I表达。这一作用有利于胆固醇的逆向转运及脂质代谢的改善。 Objective To observe the impact of lysophosphatidyl choline (LPC) on the expression of scavenger receptor class B type I (SRBI) in L-20 cells and the impact of simvastatin. Methods Cultured hepatocytes were randomly assigned to normal group, LPC-damaged group and simvastatin group. The changes of mRNA and protein expression of SRBI in hepatic tissue were assayed by RT-PCR, immunocytochemistry and Western blot, respectively. Results The expression of SRBI was higher in LPC-damaged hepatocytes than that in normal cells at both mRNA and protein level (P 〈 0.05). The hepatocytes of simvastatin group showed higher levels of mRNA and protein expression of SRBI as compared with LPC-damaged hepatocytes (P 〈 0.05). Conclusions The expressions of SRBI mRNA and protein in LPC-treated hepatocytes are increased compensatively. Simvastatin treatment can significantly up-regulate the expression of SRBI mRNA and protein in cultured hepatocytes, which is effective for the contra-transport of cholesterol and the metabolism of lipid.
出处 《中国医师杂志》 CAS 2006年第3期345-347,共3页 Journal of Chinese Physician
关键词 溶血磷脂酰胆碱类 斯伐他汀 基因 肝细胞 免疫受体 干预作用 Lysophosphatidylcholines Simvastatin Genes Hepatocytes Receptors, immunologic
  • 相关文献

参考文献9

  • 1Acton S,Rigotti A,Landschulz K T,et al.Identification of scavenger receptor SRBI as a high density lipoprotein receptor.Science,1996,271:518-520.
  • 2Arai T,Wang N,Bezouevski M,et al.Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene.J Biol Chem,1999,22,274 (4):2366-2371.
  • 3Han J,Parsons M,Zhou X,et al.Functional interplay between the macrophage scavenger receptor class B type I and pitavastatin (NK-104).Circulation,2004,110(22):3472-3479.
  • 4Kugiyama K,Kems SA,Morrisett JD et al.Impairment Of endothelium-dependent arterial relaxtion by lysolecithin in modified lowdensity lipoprotein.Nature,1990,344:160-162.
  • 5Yokoyama M,Hirata K,Miyake R,et al.Lysophosphatidycholine,essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein.Biochem Biophys Res Commun,1990,168:301-308.
  • 6Khovidhunkit W,Moser A H,Shigenaga J K,et al.Regulation of scavenger receptor class B type I in hamster liver and Hep3B cells by endotoxin and cytokine.J Lipid Res,2001,42 (10):1636-1644.
  • 7Arai T,Wang N,Bezouevski M,et al.Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene.J Biol Chem,1999,22,274 (4):2366-2371.
  • 8Trigatti B,Rayburn H,Vinals M,et al.Influence of the high density lipoprotein receptor SRBI on reproductive and cardiovascular pathophysiology.Proc Natl Acad Sci USA,1999,96 (16):9322-9327.
  • 9Acton SL,Kozarsky KF,Rigotti A.The HDL receptor SR-BI:a new therapeutic target for atherosclerosis? Mol Med Today,1999,5 (12):518-524.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部